These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure With Preserved Ejection Fraction. Prenner SB; Pillutla R; Yenigalla S; Gaddam S; Lee J; Obeid MJ; Ans AH; Jehangir Q; Kim J; Zamani P; Mazurek JA; Akers SR; Chirinos JA J Am Heart Assoc; 2020 Feb; 9(3):e014716. PubMed ID: 32009529 [TBL] [Abstract][Full Text] [Related]
28. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632 [TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N; ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002 [TBL] [Abstract][Full Text] [Related]
30. Prevalence, Presentation, and Outcome of Heart Failure with Preserved Ejection Fraction among Patients Presenting with Undifferentiated Dyspnoea to the Emergency Room: A 10-year Analysis from a Tertiary Centre. Ruan W; Lim SH; Ding ZP; Sim DK; Gao F; Gunasegaran K; Kwok BW; Tan RS Ann Acad Med Singap; 2016 Jan; 45(1):18-26. PubMed ID: 27118225 [TBL] [Abstract][Full Text] [Related]
31. Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction. Hieda M; Sarma S; Hearon CM; Dias KA; Martinez J; Samels M; Everding B; Palmer D; Livingston S; Morris M; Howden E; Levine BD Circulation; 2020 Jan; 141(2):115-123. PubMed ID: 31865771 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study. García-Pavía P; García-Pinilla JM; Lozano-Bahamonde A; Yun S; García-Quintana A; Gavira-Gómez JJ; Aibar-Arregui MÁ; Barge-Caballero G; Núñez Villota J; Bernal L; Tarilonte P Rev Esp Cardiol (Engl Ed); 2024 Jul; ():. PubMed ID: 39089574 [TBL] [Abstract][Full Text] [Related]
33. Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis. Alonso M; Neicheril RK; Manla Y; McDonald ML; Sanchez A; Lafave G; Seijo De Armas Y; Camargo AL; Uppal D; Wolinsky D; Thakkar-Rivera N; Velez M; Baran DA; Estep JD; Snipelisky D ESC Heart Fail; 2024 Aug; ():. PubMed ID: 39180423 [TBL] [Abstract][Full Text] [Related]
34. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246 [TBL] [Abstract][Full Text] [Related]
35. Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. D'Assante R; Arcopinto M; Rengo G; Salzano A; Walser M; Gambino G; Monti MG; Bencivenga L; Marra AM; Åberg DN; De Vincentiis C; Ballotta A; Bossone E; Isgaard J; Cittadini A ESC Heart Fail; 2021 Apr; 8(2):1681-1686. PubMed ID: 33512777 [TBL] [Abstract][Full Text] [Related]
36. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction. Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811 [TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction]. Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276 [No Abstract] [Full Text] [Related]
38. Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction. Tamaki S; Mano T; Sakata Y; Ohtani T; Takeda Y; Kamimura D; Omori Y; Tsukamoto Y; Ikeya Y; Kawai M; Kumanogoh A; Hagihara K; Ishii R; Higashimori M; Kaneko M; Hasuwa H; Miwa T; Yamamoto K; Komuro I PLoS One; 2013; 8(7):e68893. PubMed ID: 23894370 [TBL] [Abstract][Full Text] [Related]
39. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425 [TBL] [Abstract][Full Text] [Related]
40. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]